Horizon 2020 Launched with €15 Billion over First Two Years

European CommissionThe European Commission has for the first time presented calls for projects under Horizon 2020, the European Union's €80 billion research and innovation programme. Worth more than €15 billion over the first two years, the funding is intended to help boost Europe's knowledge-driven economy, and tackle issues that will make a difference in people's lives. This includes 12 areas that will be a focus for action in 2014/2015, including topics such as personalised healthcare, digital security and smart cities.

European Research, Innovation and Science Commissioner Máire Geoghegan-Quinn said: "It's time to get down to business. Horizon 2020 funding is vital for the future of research and innovation in Europe, and will contribute to growth, jobs and a better quality of life. We have designed Horizon 2020 to produce results, and we have slashed red tape to make it easier to participate. So I am calling on researchers, universities, businesses including SMEs, and others to sign up!"

For the first time, the Commission has indicated funding priorities over two years, providing researchers and businesses with more certainty than ever before on the direction of EU research policy. Most calls from the 2014 budget are already open for submissions as of today, with more to follow over the course of the year. Calls in the 2014 budget alone are worth around €7.8 billion, with funding focused on the three key pillars of Horizon 2020:

  • Excellent Science: Around €3 billion, including €1.7 billion for grants from the European Research Council for top scientists and €800 million for Marie Skłodowska-Curie fellowships for younger researchers.
  • Industrial Leadership: €1.8 billion to support Europe's industrial leadership in areas like ICT, nanotechnologies, advanced manufacturing, robotics, biotechnologies and space.
  • Societal challenges: €2.8 billion for innovative projects addressing Horizon 2020's seven societal challenges, broadly: health; agriculture, maritime and bioeconomy; energy; transport; climate action, environment, resource efficiency and raw materials; reflective societies; and security.

Horizon 2020 is the EU's biggest ever research and innovation framework programme with a seven year budget worth nearly €80 billion. Most EU research funding is allocated on the basis of competitive calls, but the budget for Horizon includes funding also for the Joint Research Centre, the European Commission's in-house science service; the European Institute for Innovation and Technology and research carried out within the framework of the Euratom Treaty. Separate calls will also be published under specific Partnerships with industry and with Member States. In 2014 the total EU research budget, including these items and administrative expenditure, will be around €9.3 billion, rising to around €9.9 billion in 2015. Final 2015 amounts are subject to the decision on the 2015 annual budget.

The funding opportunities under Horizon 2020 are set out in work programmes published on the EU's digital portal for research funding, which has been redesigned for quicker, paperless procedures. Participants will also find simpler programme architecture and funding, a single set of rules, and a reduced burden from financial controls and audits.

The 2014-15 calls include €500 million over two years dedicated to innovative small and medium-sized enterprises (SMEs) through a brand new SME Instrument. Gender aspects are expected to be included in many of the projects, and there is funding to further stimulate debate on science's role within society. There are also new rules to make 'open access' a requirement for Horizon 2020, so that publications of project results are freely accessible to all.

For further information, please visit:
http://ec.europa.eu/research/participants/portal/desktop/en/home.html

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...